Press Releases
Jan. 27, 2026
Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
Indeterminate
GlobeNewswire, Inc.
Jan. 27, 2026
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
Indeterminate
GlobeNewswire, Inc.
Jan. 27, 2026
Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC
Indeterminate
GlobeNewswire, Inc.
Jan. 27, 2026
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Indeterminate
GlobeNewswire, Inc.
Jan. 20, 2026
New Jonathan Grave Thriller 'Scorched Earth' Raises the Stakes in John Gilstrap’s Bestselling Series
Neutral
EIN Presswire
Jan. 23, 2026
Illusions In Sherwood Reimagines A Legendary Forest Where Magic, Betrayal, And Forbidden Love Collide
Neutral
EIN Presswire
Jan. 22, 2026
FBI Case File Review Podcast Marks 10 Years of Sharing FBI Stories
Neutral
EIN Presswire
Jan. 26, 2026
From Ideas to Impact: NPS Patents Power Defense Innovation
Neutral
EIN Presswire
Jan. 26, 2026
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program
Indeterminate
GlobeNewswire, Inc.
Jan. 26, 2026
Advanced Technology International to Manage Maritime Advanced Technology Accelerator Consortium (MATAC) OTA
Indeterminate
GlobeNewswire, Inc.
Jan. 24, 2026
Semiotica Cybernetics Introduces Solution to Achieve Artificial General and Super Intelligence (AGI/ASI)
Indeterminate
GlobeNewswire, Inc.
Jan. 26, 2026
AI sharpens satellite eyes on air pollution
Neutral
EIN Presswire
Jan. 23, 2026
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
Indeterminate
GlobeNewswire, Inc.
Jan. 21, 2026
Frankenstein film is now available on Amazon Prime Video
Neutral
EIN Presswire
